[Therapy of hyperlipidemia].
D000475:Alkenes; D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control; D002784:Cholesterol / Q000096:biosynthesis; D002994:Clofibrate / Q000627:therapeutic use; D004035:Diet Therapy; D005227:Fatty Acids / Q000096:biosynthesis; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000096:biosynthesis; D010084:Oxidation-Reduction; D051381:Rats; D013974:Thyroxine / Q000627:therapeutic use
D000475:Alkenes; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D002784:Cholesterol; D002994:Clofibrate; D013974:Thyroxine
Die Therapie von Hyperlipidämien.